Medical disclaimer: Peptide Clinic Finder is an informational directory and does not diagnose, prescribe, or recommend treatments. Always consult a qualified clinician for medical decisions.

MK-677 vs Ipamorelin

Both are referenced as growth hormone secretagogues in performance and longevity clinic listings. MK-677 is orally active while ipamorelin is typically injectable. Compare clinic listings by service scope and monitoring protocols.

MK-677 and ipamorelin are often referenced in performance or longevity contexts. Clinics vary in how they position each option within protocols. Use this page to compare provider models and monitoring standards.

MK-677

A growth hormone secretagogue referenced in performance and longevity clinic listings. Not a peptide in the traditional sense.

Potential benefits

  • Often listed in performance-focused protocols.
  • Common in longevity clinic menus.

Considerations

  • Regulatory status varies.
  • Requires clinician-led assessment.
Best for: Comparing performance clinics and their monitoring models.

Ipamorelin

A GH secretagogue typically administered by injection in clinic protocols.

Potential benefits

  • Often paired with other secretagogues.
  • Common in longevity listings.

Considerations

  • Human evidence is limited.
  • Monitoring standards vary by clinic.
Best for: Evaluating hormone optimisation clinics and protocol transparency.
CategoryMK-677Ipamorelin
Directory contextRecovery / performance-focused listing context.Weight / metabolic or longevity listing context.
Common goalsRecovery support, injury pathways, performance.Weight management, metabolic health, longevity programs.
Guidance noteInformational listing only; suitability requires clinician review.Informational listing only; suitability requires clinician review.

Related clinics

Conclusion

Choose based on provider quality and monitoring rather than delivery format. Both are clinic-dependent and require clinician oversight.

Related peptide pages